| Literature DB >> 36060280 |
Aatif Ali1, Saif Ullah2,3, Muhammad Altaf Khan4.
Abstract
The coronavirus disease 2019 (COVID-19) is a recent outbreak of respiratory infections that have affected millions of humans all around the world. Initially, the major intervention strategies used to combat the infection were the basic public health measure, nevertheless, vaccination is an effective strategy and has been used to control the incidence of many infectious diseases. Currently, few safe and effective vaccines have been approved to control the inadvertent transmission of COVID-19. In this paper, the modeling approach is adopted to investigate the impact of currently available anti-COVID vaccines on the dynamics of COVID-19. A new fractional-order epidemic model by incorporating the vaccination class is presented. The fractional derivative is considered in the well-known Caputo sense. Initially, the proposed vaccine model for the dynamics of COVID-19 is developed via integer-order differential equations and then the Caputo-type derivative is applied to extend the model to a fractional case. By applying the least square method, the model is fitted to the reported cases in Pakistan and some of the parameters involved in the models are estimated from the actual data. The threshold quantity ( R 0 ) is computed by the Next-generation method. A detailed analysis of the fractional model, such as positivity of model solution, equilibrium points, and stabilities on both disease-free and endemic states are discussed comprehensively. An efficient iterative method is utilized for the numerical solution of the proposed model and the model is then simulated in the light of vaccination. The impact of important influential parameters on the pandemic dynamics is shown graphically. Moreover, the impact of different intervention scenarios on the disease incidence is depicted and it is found that the reduction in the effective contact rate (up to 30%) and enhancement in vaccination rate (up to 50%) to the current baseline values significantly reduced the disease new infected cases.Entities:
Keywords: COVID-19 mathematical model; Data fitting; Fractional analysis; Numerical simulations; Stability; Vaccination
Year: 2022 PMID: 36060280 PMCID: PMC9420075 DOI: 10.1007/s11071-022-07798-5
Source DB: PubMed Journal: Nonlinear Dyn ISSN: 0924-090X Impact factor: 5.741
Biological description of parameters with corresponding estimated values
| Details | Time unit per/day | Source | |
|---|---|---|---|
| Recruitment rate | Estimated | ||
| Natural death rate | [ | ||
| Infection-induced mortality rate | 0.022 | [ | |
| Recovery rate of individuals in | 0.4958 | Fitted | |
| Recovery rate of individuals in | 0.1110 | Fitted | |
| Disease transmission rate | 0.6022 | Fitted | |
| Transmissibility relative to | 0.7459 | Fitted | |
| Transmission rate from | 0.5171 | Fitted | |
| Proportion of exposed people join | 0.8833 | Fitted | |
| Vaccination rate of susceptible class | 0.0313 | Fitted | |
| loss of immunity | 0.0233 | Fitted |
Fig. 1Observed COVID-19 cases in Pakistan (red circles) and the model predicted cumulative infected cases (blue solid line). The data taken for the period from 1 March to 31 July 2020
The sensitivity indices of model parameters
| sensitivity | |
|---|---|
| −0.0015545 | |
| −0.0350339 | |
| −0.963058 | |
| +1.000 | |
| +0.963409 | |
| +0.000078 | |
| + 0.68645 | |
| −0.572835 | |
| +0.571842 |
Fig. 2Dynamics of COVID-19 fractional model with vaccination (2) for different values of
Fig. 4The impact of reduction in community contact rate (through social-distancing) on cumulative asymptomatic COVID-19 cases for and
Fig. 5Influence of reduction in contact rate relative to asymptomatically-infected individuals versus the cumulative symptomatic COVID-19 cases for and
Fig. 6Influence of reduction in contact rate versus the cumulative asymptomatic COVID-19 cases for and
Fig. 7Graphical assessment of impact of vaccination coverage over cumulative symptomatic COVID-19 cases where, a , b
Fig. 8Graphical assessment of impact of vaccination coverage over cumulative asymptomatic COVID-19 cases where, a b
Fig. 9Assessment of variation in parameter on cumulative over cumulative symptomatic COVID-19 cases where, a , b
Fig. 10Assessment of variation in parameter on cumulative over cumulative asymptomatic COVID-19 cases where, a , b